Bots, editor, reviewer, Administrators
13,951
edits
Feed:All articles/Pretty: Difference between revisions
Jump to navigation
Jump to search
no edit summary
No edit summary |
No edit summary |
||
| Line 669: | Line 669: | ||
}, | }, | ||
{ | { | ||
"timestamp" : " | "timestamp" : "2018-09-13T18:05:44Z", | ||
"briefDesignDescription" : "Aspirin for vascular disease prevention in DM", | |||
"fulltexturl" : "https://www.nejm.org/doi/10.1056/NEJMoa1804988", | |||
"pageid" : 3698, | |||
"pdfurl" : "https://www.nejm.org/doi/pdf/10.1056/NEJMoa1804988", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Bowman L, <i>et al</i>. \"Effects of aspirin for primary prevention in persons with diabetes mellitus\". <i>The New England Journal of Medicine</i>. 2018. epub 2018-08-26:1-11.", | |||
"subspecialties" : "Cardiology", | |||
"expansion" : "A Study of Cardiovascular Events in Diabetes", | |||
"statusUsableDate" : "2018-09-06", | |||
"briefResultsDescription" : "Aspirin reduces cardiovascular events but increases bleeding vs. placebo", | |||
"published" : "2018-08-26", | |||
"pageName" : "ASCEND (Aspirin)", | |||
"diseases" : "Diabetes", | |||
"abbreviation" : "ASCEND", | |||
"title" : "Effects of aspirin for primary prevention in persons with diabetes mellitus", | |||
"pmid" : "30146931" | |||
}, | |||
{ | |||
"timestamp" : "2018-09-13T17:56:54Z", | |||
"briefDesignDescription" : "Pirfenidone in IPF", | "briefDesignDescription" : "Pirfenidone in IPF", | ||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1402582", | "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1402582", | ||
| Line 681: | Line 700: | ||
"briefResultsDescription" : "Pirfenidone reduces progression of IPF", | "briefResultsDescription" : "Pirfenidone reduces progression of IPF", | ||
"published" : "2014-05-29", | "published" : "2014-05-29", | ||
"pageName" : "ASCEND", | "pageName" : "ASCEND (IPF)", | ||
"diseases" : "Pulmonary Fibrosis", | "diseases" : "Pulmonary Fibrosis", | ||
"abbreviation" : "ASCEND", | "abbreviation" : "ASCEND", | ||
| Line 800: | Line 819: | ||
"title" : "Intensity of renal support in critically ill patients with acute kidney injury", | "title" : "Intensity of renal support in critically ill patients with acute kidney injury", | ||
"pmid" : "18492867" | "pmid" : "18492867" | ||
}, | |||
{ | |||
"timestamp" : "2018-09-13T18:04:35Z", | |||
"briefDesignDescription" : "Tafamidis vs. placebo in amyloid cardiomyopathy", | |||
"fulltexturl" : "https://www.nejm.org/doi/10.1056/NEJMoa1805689", | |||
"pageid" : 3696, | |||
"pdfurl" : "https://www.nejm.org/doi/pdf/10.1056/NEJMoa1805689", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Maurer MS, <i>et al</i>. \"Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy\". <i>The New England Journal of Medicine</i>. 2018. 379(11):1007-1016.", | |||
"subspecialties" : "Cardiology", | |||
"expansion" : "The Transthyretin Amyloidosis Cardiomyopathy Clinical Trial", | |||
"statusUsableDate" : "2018-09-05", | |||
"briefResultsDescription" : "Tafamidis superior to placebo in amyloid cardiomyopathy", | |||
"published" : "2018-08-27", | |||
"pageName" : "ATTR-ACT", | |||
"diseases" : "Heart Failure", | |||
"abbreviation" : "ATTR-ACT", | |||
"title" : "Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy", | |||
"pmid" : "30145929" | |||
}, | }, | ||
{ | { | ||
| Line 2,358: | Line 2,396: | ||
"title" : "Reduced exposure to calcineurin inhibitors in renal transplantation", | "title" : "Reduced exposure to calcineurin inhibitors in renal transplantation", | ||
"pmid" : "18094377" | "pmid" : "18094377" | ||
}, | |||
{ | |||
"timestamp" : "2018-09-13T17:28:08Z", | |||
"briefDesignDescription" : "Extended EKG monitoring after cryptogenic stroke", | |||
"fulltexturl" : "https://www.nejm.org/doi/10.1056/NEJMoa1311376", | |||
"pageid" : 2403, | |||
"pdfurl" : "https://www.nejm.org/doi/pdf/10.1056/NEJMoa1311376", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Gladstone DJ, <i>et al</i>. \"Atrial Fibrillation in Patients with Cryptogenic Stroke\". <i>The New England Journal of Medicine</i>. 2014. 370(26):2467-2477.", | |||
"subspecialties" : "Neurology;Cardiology", | |||
"expansion" : "30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation after a Cerebral Ischemic Event", | |||
"statusUsableDate" : "2018-09-13", | |||
"briefResultsDescription" : "Extended EKG monitoring detects AF more frequently than 24-hour monitoring", | |||
"published" : "2014-06-26", | |||
"pageName" : "EMBRACE", | |||
"diseases" : "Stroke;Atrial Fibrillation", | |||
"abbreviation" : "EMBRACE", | |||
"title" : "Atrial Fibrillation in Patients with Cryptogenic Stroke", | |||
"pmid" : "24963566" | |||
}, | }, | ||
{ | { | ||